Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death

C. Visco; M. C. Tisi; A. Evangelista; Rocco A. Di; Zoellner A. -K.; V. R. Zilioli; Stefan Hohaus; R. Sciarra; A. Re; C. Tecchio; A. Chiappella; L. Morello; G. Gini; L. Nassi; T. Perrone; A. L. Molinari; A. Fabbri; M. C. Cox; E. Finolezzi; S. Ferrero; B. Puccini; De Celis I. Alvarez; A. Arcari; D. Marino; M. Merli; F. Piazza; Marino Gentile; M. Pelosini; G. Loseto; O. Hermine; M. Dreyling; M. Ruggeri; M. Martelli; E. Hoster; U. Vitolo

doi:10.1111/bjh.15643

Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death

C. Visco
, M. C. Tisi
, A. Evangelista
, Rocco A. Di
, Zoellner A. -K.
, V. R. Zilioli
, Stefan Hohaus
, R. Sciarra
, A. Re
, C. Tecchio
, A. Chiappella
, L. Morello
, G. Gini
, L. Nassi
, T. Perrone
, A. L. Molinari
, A. Fabbri
, M. C. Cox
, E. Finolezzi
, S. Ferrero

B. Puccini, De Celis I. Alvarez, A. Arcari, D. Marino, M. Merli, F. Piazza, Marino Gentile, M. Pelosini, G. Loseto, O. Hermine, M. Dreyling, M. Ruggeri, M. Martelli, E. Hoster, U. Vitolo

Risultato della ricerca: Contributo in rivista › Articolo

16 Citazioni (Scopus)

Abstract

N/A

Lingua originale	Inglese
pagine (da-a)	940-944
Numero di pagine	5
Rivista	British Journal of Haematology
Volume	185
Numero di pubblicazione	5
DOI	https://doi.org/10.1111/bjh.15643
Stato di pubblicazione	Pubblicato - 2019

All Science Journal Classification (ASJC) codes

Ematologia

Keywords

allogeneic transplant
cytarabine
mantle cell lymphoma
prognosis
refractory

Accesso al documento

10.1111/bjh.15643

Altri file e collegamenti

Cita questo

Visco, C., Tisi, M. C., Evangelista, A., Di, R. A., -K., Z. A., Zilioli, V. R., Hohaus, S., Sciarra, R., Re, A., Tecchio, C., Chiappella, A., Morello, L., Gini, G., Nassi, L., Perrone, T., Molinari, A. L., Fabbri, A., Cox, M. C., Finolezzi, E., ... Vitolo, U. (2019). Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death. British Journal of Haematology, 185(5), 940-944. https://doi.org/10.1111/bjh.15643

@article{5801ac32f1024b9cb833a68d2efea8c0,

title = "Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death",

abstract = "N/A",

keywords = "allogeneic transplant, cytarabine, mantle cell lymphoma, prognosis, refractory, allogeneic transplant, cytarabine, mantle cell lymphoma, prognosis, refractory",

author = "C. Visco and Tisi, \{M. C.\} and A. Evangelista and Di, \{Rocco A.\} and -K., \{Zoellner A.\} and Zilioli, \{V. R.\} and Stefan Hohaus and R. Sciarra and A. Re and C. Tecchio and A. Chiappella and L. Morello and G. Gini and L. Nassi and T. Perrone and Molinari, \{A. L.\} and A. Fabbri and Cox, \{M. C.\} and E. Finolezzi and S. Ferrero and B. Puccini and Alvarez, \{De Celis I.\} and A. Arcari and D. Marino and M. Merli and F. Piazza and Marino Gentile and M. Pelosini and G. Loseto and O. Hermine and M. Dreyling and M. Ruggeri and M. Martelli and E. Hoster and U. Vitolo",

year = "2019",

doi = "10.1111/bjh.15643",

language = "English",

volume = "185",

pages = "940--944",

journal = "British Journal of Haematology",

issn = "1365-2141",

publisher = "John Wiley and Sons Inc.",

number = "5",

}

Visco, C, Tisi, MC, Evangelista, A, Di, RA, -K., ZA, Zilioli, VR, Hohaus, S, Sciarra, R, Re, A, Tecchio, C, Chiappella, A, Morello, L, Gini, G, Nassi, L, Perrone, T, Molinari, AL, Fabbri, A, Cox, MC, Finolezzi, E, Ferrero, S, Puccini, B, Alvarez, DCI, Arcari, A, Marino, D, Merli, M, Piazza, F, Gentile, M, Pelosini, M, Loseto, G, Hermine, O, Dreyling, M, Ruggeri, M, Martelli, M, Hoster, E & Vitolo, U 2019, 'Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death', British Journal of Haematology, vol. 185, n. 5, pagg. 940-944. https://doi.org/10.1111/bjh.15643

TY - JOUR

T1 - Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death

AU - Visco, C.

AU - Tisi, M. C.

AU - Evangelista, A.

AU - Di, Rocco A.

AU - -K., Zoellner A.

AU - Zilioli, V. R.

AU - Hohaus, Stefan

AU - Sciarra, R.

AU - Re, A.

AU - Tecchio, C.

AU - Chiappella, A.

AU - Morello, L.

AU - Gini, G.

AU - Nassi, L.

AU - Perrone, T.

AU - Molinari, A. L.

AU - Fabbri, A.

AU - Cox, M. C.

AU - Finolezzi, E.

AU - Ferrero, S.

AU - Puccini, B.

AU - Alvarez, De Celis I.

AU - Arcari, A.

AU - Marino, D.

AU - Merli, M.

AU - Piazza, F.

AU - Gentile, Marino

AU - Pelosini, M.

AU - Loseto, G.

AU - Hermine, O.

AU - Dreyling, M.

AU - Ruggeri, M.

AU - Martelli, M.

AU - Hoster, E.

AU - Vitolo, U.

PY - 2019

Y1 - 2019

N2 - N/A

AB - N/A

KW - allogeneic transplant

KW - cytarabine

KW - mantle cell lymphoma

KW - prognosis

KW - refractory

KW - allogeneic transplant

KW - cytarabine

KW - mantle cell lymphoma

KW - prognosis

KW - refractory

UR - https://publicatt.unicatt.it/handle/10807/141173

UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85056177214&origin=inward

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85056177214&origin=inward

U2 - 10.1111/bjh.15643

DO - 10.1111/bjh.15643

M3 - Article

SN - 1365-2141

VL - 185

SP - 940

EP - 944

JO - British Journal of Haematology

JF - British Journal of Haematology

IS - 5

ER -

Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death

Abstract

All Science Journal Classification (ASJC) codes

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo